Indegene Limited operates as a life sciences commercialization company in India and internationally. It helps biopharmaceutical, emerging biotech, and medical device companies develop products, get to the market, and grow impact through the life cycle. The company offers enterprise commercial solutions, enterprise medical solutions, enterprise clinical solutions, omnichannel activation solutions, and NEXT technology platforms. The company was incorporated in 1998 and is based in Bengaluru, India.

Indegene Limited

Owlpharma Consulting is a consultancy company focused on providing specialized services to the pharmaceutical and healthcare products industries, addressing various operational needs.

Owlpharma Consulting

Indegene is a digital-first life sciences commercialization company that helps biopharmaceutical, emerging biotech, and medical device companies develop products and bring them to market.

Metric
Company Name	Indegene Limited	Owlpharma Consulting
Symbol	INDGN
MSH ID	COM:INDEGENE	PT:OWLPHARMA
Market	STOCKS	PRIVATE
Sector		Commercial & Professional Services
Industry		Pharmaceuticals
Country	IN	PT
Stage
Employee Count	5.43K
Website	indegene.com	owlpharma.pt
LinkedIn
Founders

Metric
Market Cap	1.66B
Enterprise Value
Monthly Web Traffic		345
Web Traffic Growth		-0.22
Valuation
Raised Capital

Metric
Revenue	305.73M
Revenue (LTM)
Revenue (NTM)
Gross Profit	305.73M
EBITDA	59.67M
Operating Income	50.68M
Net Income	39.75M
EPS	0.18
Diluted EPS	0.18
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	1
Operating Profit Margin	0.17
EBITDA Margin	0.20
Net Profit Margin	0.13
Return on Equity	0.23
Return on Assets	0.05
Return on Capital Employed	0.10

INDG

COM:INDEGENE

Indegene

Last Close

640.30

25/11 09:40

Market Cap

140.43B

Beta: -

Volume Today

1.88M

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	116.48
P/B Ratio	10.29
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	11.01
EV Multiple	57.36

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover	0.49

Metric
Operating Cash Flow	59.94M
Free Cash Flow	58.68M
Cash Flow to Debt	0.11
Operating Cash Flow/Sales	0.08
Free Cash Flow Yield	0.00

Metric
Cash & Equivalents	22.55M
Accounts Receivable	3.68M
Inventory
Goodwill	39.31M
Debt to Capitalization	0.27
Debt to Assets	0.19
Current Ratio	2.75
Quick Ratio	2.75

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.01
R&D to Revenue
SG&A to Revenue	0.02